Teprotumumab. Anti-insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, Treatment of thyroid eye disease
-
Published:2020
Issue:1
Volume:45
Page:21
-
ISSN:0377-8282
-
Container-title:Drugs of the Future
-
language:en
-
Short-container-title:Drugs Fut
Author:
Ferro Desideri L.,Vagge A.,del Noce C.,Nicolò M.,Traverso C.E.
Publisher
Clarivate Analytics (US)
Subject
Pharmacology (medical),Pharmacology